Somatic mosaic mutations of PPM1D in the blood have been more frequently found in patients with various cancers including breast and ovarian cancers compared to control groups, raising concern that it has a possible role in cancer predisposition [5,9,12]. Here, PPM1D is linked to ovarian cancer.